TOP TIERMARKET NEWSWIRE
News & sentiment

CUE BIOPHARMA INC (CUE) — News & AI sentiment

CUE BIOPHARMA INC (CUE) news roundup. 5 stories aggregated over the last 30 days. Average 30-day sentiment is 38/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 3 sales totalling $2.0M — net selling of $2.0M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
5
avg sentiment 38/100
Insider net (90d)
$2.0M
0 buys · 3 sells
Congress (90d)
0
0 buys · 0 sells

CUE news in the last 24 hours, 7 days, 30 days and 90 days

How much CUE coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowCUE storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days538/100CUE headlines →
Last 90 days1642.5/100CUE headlines →

Latest stories on CUE

Aug 17
Aug 14
Aug 14
Aug 14
Cue Biopharma, Inc. (CUE) files 8-K
SEC 8-K50 · neutralgeneral
Aug 14
Aug 3
Cue Biopharma, Inc. (CUE) files 8-K
SEC 8-K50 · neutralgeneral
Aug 3
Cue Biopharma Names James Ahlers CFO
Morningstar59 · neutralgeneral
Aug 3
Aug 3
Jul 13
Jul 13
Jul 10
Cue Biopharma, Inc. (CUE) files 8-K
SEC 8-K50 · neutralgeneral
Jul 10
Jul 10
Jul 10
Jul 10
Jun 2
Jun 2
May 21
Open CUE in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →